<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03755609</url>
  </required_header>
  <id_info>
    <org_study_id>2018006</org_study_id>
    <nct_id>NCT03755609</nct_id>
  </id_info>
  <brief_title>Efficacy of Oxycodone-propofol Combination Compared With a Fentanyl-propofol Combination on Conscious Sedation Effect and Early Cognitive Function During Therapeutic Endoscopic Retrograde Cholangio-pancreatography</brief_title>
  <official_title>Efficacy of Oxycodone-propofol Combination Compared With a Fentanyl-propofol Combination on Conscious Sedation Effect and Early Cognitive Function During Therapeutic Endoscopic Retrograde Cholangio-pancreatography:a Prospective,Randomized, Single- Blinded Preliminary Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Changhai Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Wuhan University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Changhai Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate and compare the sedative effect and effects on early period cognitive function of
      a fentanyl-propofol Combination (FP) regimen with a oxycodone-propofol(OP) combination during
      the endoscopic retrograde cholangio-pancreatography (ERCP) requiring conscious sedation
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      One hundred patients undergoing ERCP were included in this study and randomly divided into
      two groups of 50 people each. The patients in group FP were given fentanyl infusion of 1ug/kg
      intravenously 5 minutes before the process. They were given propofol infusion: a loading does
      of 1-2mg/kg immediately before the process then maintenance does of 1mg/kg/h. The patients in
      group OP were administered oxycodone of 0.1 mg/kg and 1-2mg/kg loading dose of propofol
      intravenously 5 minutes before the process. Then they were given 1mg/kg/h maintenance does of
      propofol infusion. In order to maintenan Ramsey Sedation Scale (RSS) between 3 and 4, all
      patients were administered 0.2~0.5 mg/kg bolus of propofol when necessary. Time of induction
      of anesthesia, operation time, wake-up time, recovery time, occurrence of adverse
      cardiovascular events, bucking, nausea and vomiting and respiratory depression ,total dosage
      of used propofol were assessed.Furthermore,different time point of regional cerebral oxygen
      saturation (rScO2) ,serum levels of irisin and cognitive function by mini-mental state
      examination (MMSE) were rated.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2018</start_date>
  <completion_date type="Anticipated">March 2019</completion_date>
  <primary_completion_date type="Anticipated">January 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>anesthesia time</measure>
    <time_frame>2 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>operation time</measure>
    <time_frame>2 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>irisin</measure>
    <time_frame>2 hours</time_frame>
    <description>serum levels of irisin</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Conscious Sedation During Endoscopic Retrograde Choledochopancreatography</condition>
  <arm_group>
    <arm_group_label>patients with oxycodone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>patients with fentanyl</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxycodone</intervention_name>
    <description>0.1 mg/kg intravenously</description>
    <arm_group_label>patients with oxycodone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>fentanyl</intervention_name>
    <description>1ug/kg intravenously</description>
    <arm_group_label>patients with fentanyl</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA I-III

        Exclusion Criteria:

          -  cardiovascular disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Qiu Zhao, MD, PhD</last_name>
    <phone>13971605755</phone>
    <email>zhaoqiuwhugi@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Changhai Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200433</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>bai bai, M.D</last_name>
      <phone>021-81873241</phone>
      <email>baiyu1998@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>fang jun, M.D</last_name>
      <phone>021-81873241</phone>
      <email>XHFANGJUN@163.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>November 16, 2018</study_first_submitted>
  <study_first_submitted_qc>November 27, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 28, 2018</study_first_posted>
  <last_update_submitted>November 27, 2018</last_update_submitted>
  <last_update_submitted_qc>November 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 28, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Changhai Hospital</investigator_affiliation>
    <investigator_full_name>fangjun</investigator_full_name>
    <investigator_title>physician</investigator_title>
  </responsible_party>
  <keyword>Endoscopic Retrograde Choledochopancreatography</keyword>
  <keyword>sedation</keyword>
  <keyword>fentanyl</keyword>
  <keyword>oxycodonel</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Oxycodone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

